Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifei Qingchang Granules for Stable Bronchiectasis
NCT07523165Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Apr 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lifei Qingchang Granules in bronchiectasis, sponsored by The First Affiliated Hospital of Guangzhou Medical University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
Lifei Qingchang Granules
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT07523165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07523165.